Santiago Vega

Drug Supply & QA Director at Highlight Therapeutics SL - , ,

Santiago Vega's Contact Details
HQ
Location
Las Rozas,Community of Madrid,Spain
Company
Highlight Therapeutics SL
Santiago Vega's Company Details
Highlight Therapeutics SL logo, Highlight Therapeutics SL contact details

Highlight Therapeutics SL

, , • 1 - 10 Employees
Biotechnology

Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology. Its lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target approach to turn ‘cold' tumors ‘hot' and therefore visible to the immune system. It has the potential to rescue patients who are resistant to current checkpoint inhibitor therapy. BO-112 is currently being investigated in a range of clinical trials as a monotherapy and in combination with checkpoint inhibitors. In addition to in-house research, Highlight Therapeutics has a number of external collaborators, including Merck & Co and UCLA.

Details about Highlight Therapeutics SL
Frequently Asked Questions about Santiago Vega
Santiago Vega currently works for Highlight Therapeutics SL.
Santiago Vega's role at Highlight Therapeutics SL is Drug Supply & QA Director.
Santiago Vega's email address is ***@highlighttherapeutics.com. To view Santiago Vega's full email address, please signup to ConnectPlex.
Santiago Vega works in the Research industry.
Santiago Vega's colleagues at Highlight Therapeutics SL are Mark Branum, Mercedes Rubio, Idoia Herrero, Elena Castellote, Juan Quesada, Arianne Munoz and others.
Santiago Vega's phone number is
See more information about Santiago Vega